Blinding and bias in randomized controlled trials: when to measure the effectiveness of blinding

Lisa Copeland¹, Priya Edwards¹, Leanne Sakzewski², Megan Thorley¹, Megan Kentish¹, Robert S Ware³, Roslyn N Boyd²

Affiliations

¹ Queensland Paediatric Rehabilitation Service, Queensland Children's Hospital, South Brisbane, Queensland, Australia.
² Queensland Cerebral Palsy and Rehabilitation Research Centre, The University of Queensland, Brisbane, Queensland, Australia.
³ Menzies Health Institute Queensland, Griffith University, Gold Coast, Queensland, Australia.

PMID: 31571206
DOI: 10.1111/dmcn.14369

Free article

Comment

Blinding and bias in randomized controlled trials: when to measure the effectiveness of blinding

Lisa Copeland et al. Dev Med Child Neurol. 2020 Feb.

Free article

. 2020 Feb;62(2):260.

doi: 10.1111/dmcn.14369. Epub 2019 Sep 30.

Authors

Lisa Copeland¹, Priya Edwards¹, Leanne Sakzewski², Megan Thorley¹, Megan Kentish¹, Robert S Ware³, Roslyn N Boyd²

Affiliations

¹ Queensland Paediatric Rehabilitation Service, Queensland Children's Hospital, South Brisbane, Queensland, Australia.
² Queensland Cerebral Palsy and Rehabilitation Research Centre, The University of Queensland, Brisbane, Queensland, Australia.
³ Menzies Health Institute Queensland, Griffith University, Gold Coast, Queensland, Australia.

PMID: 31571206
DOI: 10.1111/dmcn.14369

No abstract available

PubMed Disclaimer

Comment in

Success or failure of blinding in randomized controlled trials.
Day SM. Day SM. Dev Med Child Neurol. 2020 Feb;62(2):159. doi: 10.1111/dmcn.14388. Epub 2019 Oct 31. Dev Med Child Neurol. 2020. PMID: 31670394 No abstract available.

Comment on

Botulinum toxin A for nonambulatory children with cerebral palsy: a double blind randomized controlled trial.
Copeland L, Edwards P, Thorley M, Donaghey S, Gascoigne-Pees L, Kentish M, Cert G, Lindsley J, McLennan K, Sakzewski L, Boyd RN. Copeland L, et al. J Pediatr. 2014 Jul;165(1):140-146.e4. doi: 10.1016/j.jpeds.2014.01.050. Epub 2014 Mar 12. J Pediatr. 2014. PMID: 24630348 Clinical Trial.
Botulinum neurotoxin A, blinding, and bias.
Hastings-Ison T, Graham K. Hastings-Ison T, et al. Dev Med Child Neurol. 2020 Feb;62(2):259. doi: 10.1111/dmcn.14297. Epub 2019 Jun 21. Dev Med Child Neurol. 2020. PMID: 31225641 No abstract available.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley
Medical
- MedlinePlus Consumer Health Information
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Blinding and bias in randomized controlled trials: when to measure the effectiveness of blinding

Affiliations

Blinding and bias in randomized controlled trials: when to measure the effectiveness of blinding

Authors

Affiliations

Comment in

Comment on

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Medical